May Measurement Month 2019: an analysis of blood pressure screening results from Albania.

Albania Blood pressure Control Hypertension Screening Treatment

Journal

European heart journal supplements : journal of the European Society of Cardiology
ISSN: 1520-765X
Titre abrégé: Eur Heart J Suppl
Pays: England
ID NLM: 100886647

Informations de publication

Date de publication:
May 2021
Historique:
entrez: 4 11 2021
pubmed: 5 11 2021
medline: 5 11 2021
Statut: epublish

Résumé

This article discusses the results of the May Measurement Month (MMM) 2019 campaign, which contributed to a third round of MMM hypertension screening campaigns carried out in Albania, a transitional country in the Western Balkans. The hypertension screening campaign in Albania was carried out during the period 1-31 May 2019 in 30 sites in many districts of the country. Overall, 19 154 participants aged ≥18 years were included (approximately 68% of these were women), with an overall mean age of 47.0 ± 15.3 years. Blood pressure (BP) was measured with OMRON sphygmomanometers (Omron Healthcare, Kyoto, Japan). Hypertension was defined as systolic BP ≥140 mmHg, or diastolic BP ≥90 mmHg, or on treatment for hypertension. Self-reported data consisted of height and weight, pre-existing conditions, including smoking status and alcohol consumption. Overall, the proportion of participants with hypertension was 38.6%. Less than two-thirds (64.7%) of hypertensive individuals were aware of their condition. Also, less than half (48.3%) of participants on antihypertensive medication had controlled BP (<140/90 mmHg). The most sizable correlations of high BP were with known hypertension status, use of antihypertensive medication, and obesity. The MMM campaign contributes to routine hypertension screening in Albania. Hence, health professionals and policymakers in Albania should act on the findings of MMM screening campaigns and continue its support as a valuable tool for early detection of hypertension in the general population.

Identifiants

pubmed: 34733123
doi: 10.1093/eurheartj/suab015
pii: suab015
pmc: PMC8559333
doi:

Types de publication

Journal Article

Langues

eng

Pagination

B6-B8

Informations de copyright

Published on behalf of the European Society of Cardiology. © The Author(s) 2021.

Références

Eur J Public Health. 2018 Dec 1;28(6):1163-1168
pubmed: 29579218
Hypertension. 2020 Aug;76(2):333-341
pubmed: 32419505
Eur Heart J Suppl. 2020 Aug;22(Suppl H):H5-H7
pubmed: 32884455

Auteurs

Gentiana Qirjako (G)

Faculty of Medicine, University of Medicine, Rr. "Dibres", No. 371, Tirana, Albania.
Institute of Public Health, Rr. "Aleksander Moisiu", No. 80, Tirana, Albania.

Iris Mone (I)

Faculty of Medicine, University of Medicine, Rr. "Dibres", No. 371, Tirana, Albania.

Thomas Beaney (T)

Imperial Clinical Trials Unit, Imperial College London, Stadium House, 68 Wood Lane, London W12 7RH, UK.
Department of Primary Care and Public Health, Imperial College London, St Dunstan's Road, London W6 8RP, UK.

Xin Xia (X)

Imperial Clinical Trials Unit, Imperial College London, Stadium House, 68 Wood Lane, London W12 7RH, UK.

Xheladin Draçini (X)

Faculty of Medicine, University of Medicine, Rr. "Dibres", No. 371, Tirana, Albania.

Neil R Poulter (NR)

Imperial Clinical Trials Unit, Imperial College London, Stadium House, 68 Wood Lane, London W12 7RH, UK.

Albana Fico (A)

Faculty of Medicine, University of Medicine, Rr. "Dibres", No. 371, Tirana, Albania.
Institute of Public Health, Rr. "Aleksander Moisiu", No. 80, Tirana, Albania.

Alban Ylli (A)

Faculty of Medicine, University of Medicine, Rr. "Dibres", No. 371, Tirana, Albania.
Institute of Public Health, Rr. "Aleksander Moisiu", No. 80, Tirana, Albania.

Rudina Çumashi (R)

Institute of Public Health, Rr. "Aleksander Moisiu", No. 80, Tirana, Albania.

Enver Roshi (E)

Faculty of Medicine, University of Medicine, Rr. "Dibres", No. 371, Tirana, Albania.

Genc Burazeri (G)

Faculty of Medicine, University of Medicine, Rr. "Dibres", No. 371, Tirana, Albania.
Department of International Health, School CAPHRI (Care and Public Health Research Institute), Maastricht University, P.O. Box 616, 6200 MD, Maastricht, The Netherlands.

Classifications MeSH